Tag: Prescription Drugs
Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
Longer median time of flare-free maintenance, greater number of flare-free days, and lower mean number of flares
FDA Approves Litfulo for Teens, Adults With Alopecia Areata
Approval based on clinical trials, including ALLEGRO Phase 2b/3 trial involving 718 patients with alopecia areata
ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
Substantial and clinically meaningful reductions in body weight seen for adults with obesity and type 2 diabetes
ADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
Superior and clinically meaningful reduction in body weight in adults with overweight, obesity without type 2 diabetes
Adaptation to Pharmacotherapy Does Not Up Smoking Cessation in Black Adults
No significant difference in verified seven-day abstinence seen by treatment group among Black adults who smoke daily
FDA Approves Subcutaneous Vyvgart Hytrulo for Generalized Myasthenia Gravis
Trial shows similar reductions in anti-acetylcholine receptor antibody levels to the intravenous formulation
ADA: Once-Daily Orforglipron Linked to Significant Weight Reduction
Weight reduction of at least 10 percent occurred in 46 to 75 percent receiving orforglipron by week 36
ADA: Bempedoic Acid Cuts MACE in Statin-Intolerant Patients
Significant risk reduction in primary end point of composite of cardiovascular death nonfatal myocardial infarction, nonfatal stroke, coronary revascularization
Second-Line Switch to Dolutegravir Noninferior in HIV
Switch noninferior for patients without genotype information with viral suppression while receiving regimen containing ritonavir-boosted protease inhibitor
Continuous Meropenem No Benefit in Critically Ill Patients With Sepsis
No improvement seen in composite of all-cause mortality and emergence of pandrug- or extensively drug-resistant bacteria
